Keros Therapeutics logo
Keros Therapeutics KROS
$ 55.79 3.62%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Keros Therapeutics Accounts Payables 2011-2024 | KROS

Annual Accounts Payables Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.45 M 3.34 M 3.64 M 2.15 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.45 M 2.15 M 3.65 M

Quarterly Accounts Payables Keros Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
4.98 M 6.54 M 4.99 M 5.45 M 3.87 M 4.15 M 4.68 M 3.34 M 2.66 M - 3.06 M 3.64 M 2.81 M 1.37 M 3.01 M 2.15 M 2.15 M 2.15 M 2.15 M 2.09 M 2.09 M 2.09 M 2.09 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
6.54 M 1.37 M 3.25 M